Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial
Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. The update does not modify study content or data on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision label updated from v3.4.2 to v3.4.3. No changes to study data or visible content.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and the old Revision: v3.4.1 entry were removed.SummaryDifference0.3%

- Check49 days agoChange DetectedA system-wide notice about potential data delays due to a lapse in government funding has been added, with links to cc.nih.gov and opm.gov. The page version has been updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check56 days agoChange DetectedShow glossary option added and minor wording tweaks to QC-related labels and revision references. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, indicating a minor maintenance update.SummaryDifference0.0%

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.